Type III secretion proteins PcrV and PcrG from Pseudomonas aeruginosa form a 1:1 complex through high affinity interactions -: art. no. 21

被引:25
作者
Nanao, M [1 ]
Ricard-Blum, S [1 ]
Di Guilmi, AM [1 ]
Lemaire, D [1 ]
Lascoux, D [1 ]
Chabert, J [1 ]
Attree, I [1 ]
Dessen, A [1 ]
机构
[1] UJF, CEA, CNRS, Inst Biol Struct, F-38027 Grenoble, France
关键词
D O I
10.1186/1471-2180-3-21
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Pseudomonas aeruginosa, an increasingly prevalent opportunistic pathogen, utilizes a type III secretion system for injection of toxins into host cells in order to initiate infection. A crucial component of this system is PcrV, which is essential for cytotoxicity and is found both within the bacterial cytoplasm and localized extracellularly, suggesting that it may play more than one role in Pseudomonas infectivity. LcrV, the homolog of PcrV in Yersinia, has been proposed to participate in effector secretion regulation by interacting with LcrG, which may act as a secretion blocker. Although PcrV also recognizes PcrG within the bacterial cytoplasm, the roles played by the two proteins in type III secretion in Pseudomonas may be different from the ones suggested for their Yersinia counterparts. Results: In this work, we demonstrate by native mass spectrometry that PcrV and PcrG expressed and purified from E. coli form a 1:1 complex in vitro. Circular dichroism results indicate that PcrG is highly unstable in the absence of PcrV; in contrast, both PcrV alone and the PcrV: PcrG complex have high structural integrity. Surface plasmon resonance measurements show that PcrV interacts with PcrG with nanomolar affinity (15.6 nM) and rapid kinetics, an observation which is valid both for the full-length form of PcrG (residues 1-98) as well as a form which lacks the C-terminal 24 residues, which are predicted to have low secondary structure content. Conclusions: PcrV is a crucial component of the type III secretion system of Pseudomonas, but the way in which it participates in toxin secretion is not understood. Here we have characterized the interaction between PcrV and PcrG in vitro, and shown that PcrG is highly unstable. However, it associates readily with PcrV through a region located within its first 74 amino acids to form a high affinity complex. The fact that PcrV associates and dissociates quickly from an unstable molecule points to the transient nature of a PcrV:PcrG complex. These results are in agreement with analyses from pcrV deletion mutants which suggest that PcrV:PcrG may play a different role in effector secretion than the one described for the LcrV:LcrG complex in Yersinia.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 25 条
  • [1] Protein binding between PcrG-PcrV and PcrH-PopB/PopD encoded by the pcrGVH-popBD operon of the Pseudomonas aeruginosa type III secretion system
    Allmond, LR
    Karaca, TJ
    Nguyen, VN
    Nguyen, T
    Wiener-Kronish, JP
    Sawa, T
    [J]. INFECTION AND IMMUNITY, 2003, 71 (04) : 2230 - 2233
  • [2] Structure and composition of the Shigella flexneri 'needle complex', a part of its type III secreton
    Blocker, A
    Jouihri, N
    Larquet, E
    Gounon, P
    Ebel, F
    Parsot, C
    Sansonetti, P
    Allaoui, A
    [J]. MOLECULAR MICROBIOLOGY, 2001, 39 (03) : 652 - 663
  • [3] Helical structure of the needle of the type III secretion system of Shigella flexneri
    Cordes, FS
    Komoriya, K
    Larquet, E
    Yang, SX
    Egelman, EH
    Blocker, A
    Lea, SM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (19) : 17103 - 17107
  • [4] Assembly and function of type III secretory systems
    Cornelis, GR
    Van Gijsegem, F
    [J]. ANNUAL REVIEW OF MICROBIOLOGY, 2000, 54 : 735 - 774
  • [5] Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils
    Dacheux, D
    Toussaint, B
    Richard, M
    Brochier, G
    Croize, J
    Attree, I
    [J]. INFECTION AND IMMUNITY, 2000, 68 (05) : 2916 - 2924
  • [6] Pore-forming activity of type III system-secreted proteins leads to oncosis of Pseudomonas aeruginosa-infected macrophages
    Dacheux, D
    Goure, J
    Chabert, J
    Usson, Y
    Attree, I
    [J]. MOLECULAR MICROBIOLOGY, 2001, 40 (01) : 76 - 85
  • [7] Roles of LcrG and LcrV during type III targeting of effector Yops by Yersinia enterocolitica
    DeBord, KL
    Lee, VT
    Schneewind, O
    [J]. JOURNAL OF BACTERIOLOGY, 2001, 183 (15) : 4588 - 4598
  • [8] Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV
    Frank, DW
    Vallis, A
    Wiener-Kronish, JP
    Roy-Burman, A
    Spack, EG
    Mullaney, BP
    Megdoud, M
    Marks, JD
    Fritz, R
    Sawa, T
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (01) : 64 - 73
  • [9] The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases
    Goehring, UM
    Schmidt, G
    Pederson, KJ
    Aktories, K
    Barbieri, JT
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (51) : 36369 - 36372
  • [10] Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization
    Hill, J
    Leary, SEC
    Griffin, KF
    Williamson, ED
    Titball, RW
    [J]. INFECTION AND IMMUNITY, 1997, 65 (11) : 4476 - 4482